M&A Deal Summary |
|
|---|---|
| Date | 2017-04-19 |
| Target | InPharmics Hospital Pharmacy Consulting |
| Sector | Information Technology |
| Buyer(s) | Omnicell |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Information Technology |
| Employees | 3,590 |
| Revenue | 1.1B USD (2023) |
Omnicell is a supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. Omnicell was founded in 1992 and is based in Fort Worth, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 13 |
| Sector (Information Technology) | 5 of 7 |
| Type (Add-on Acquisition) | 7 of 10 |
| State (Mississippi) | 1 of 1 |
| Country (United States) | 5 of 9 |
| Year (2017) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-29 |
Ateb Canada
Markham, Ontario, Canada Ateb Canada Ltd. is a provider of pharmacy-based patient care products and solutions to independent and chain pharmacies. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-12 |
Pharmaceutical Strategies Group - 340B Software-Enabled Service Business
Plano, Texas, United States Pharmaceutical Strategies Group LLC - 340B Software-Enabled Service Business provides a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner. |
Buy | $225M |
